Biotech

Hansa touts phase 2 data of one-trick pony transplant therapy

Hansa Biopharma has new phase 2 data showing that its top asset beat out standard of care in treating antibody-mediated resistance.
Max Bayer Nov 28, 2022 3:35pm

Tapping mRNA to develop elusive universal flu vaccine

Nov 28, 2022 12:43pm

The future of Alzheimer’s disease research needs solutions

Nov 28, 2022 8:00am

Fierce Biotech Layoff Tracker: Spectrum, Synthego and more

Nov 28, 2022 12:21pm
image-icon

The importance of a fully enabled clinical supply platform

Nov 28, 2022 8:00am

Bionaut Labs secures $43M for its tiny, drug-carrying robots

Nov 28, 2022 11:48am
MedTech News

GE Healthcare unveils AI program bundle for simplified MRI scans

Nov 28, 2022 11:30am

Should seniors risk major surgery? New research offers guidance

Nov 28, 2022 9:15am

Aidoc AIs cleared to spot aortic tears, medium-vessel strokes

Nov 28, 2022 9:00am

Study proves accuracy of Viz.ai’s aortic dissection-spotting AI

Nov 23, 2022 12:45pm